(Q37879908)

24 August 2017

1 reference

title

A role for interleukin-33 in T(H)2-polarized intestinal inflammation? (English)

1 reference

24 August 2017

0 references

0 references

Jakob Benedict Seidelin

series ordinal

1

1 reference

24 August 2017

3

1 reference

24 August 2017

G Rogler

2

1 reference

24 August 2017

publication date

25 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

4

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

496-502

1 reference

https://scigraph.springernature.com/pub.10.1038/mi.2011.22

24 August 2017

exact match

0 references

cites work

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 is upregulated in colonocytes of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The IL-1 family: regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Expression and regulation of interleukin-33 in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 is biologically active independently of caspase-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Increased IL-33 expression by epithelial cells in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33-activated dendritic cells induce an atypical TH2-type response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 can promote survival, adhesion and cytokine production in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The cytokine interleukin-33 mediates anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

TRAF6 is a critical signal transducer in IL-33 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 is a chemoattractant for human Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

New insights into the mechanism of IL-1beta maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Inflammatory caspases and inflammasomes: master switches of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Interleukin-33 - cytokine of dual function or novel alarmin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Cell death by necrosis: towards a molecular definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

HMGB1: a signal of necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Regulation of pathogenesis and immunity in helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Induction of IL-33 expression and activity in central nervous system glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Defects in mucosal immunity leading to ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

MAP kinases in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.22

7 January 2021

Identifiers

DOI

10.1038/MI.2011.22

1 reference

24 August 2017

1 reference